Therapeutic Asset Ratings

1,179 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
G 207 Epithelial Neoplasm	M.D. Anderson Cancer Center	P1	CC (43)
G 207 Nervous System Neoplasm	M.D. Anderson Cancer Center	P1	CC (43)
G 207 Neuroepithelial Neoplasm	M.D. Anderson Cancer Center	P1	CC (43)
G 207 Nervous System Cancer	M.D. Anderson Cancer Center	P1	CC (43)
G 207 Nervous System Disorder	M.D. Anderson Cancer Center	P1	CC (43)
G 207 Viral Infectious Disease	M.D. Anderson Cancer Center	P1	CC (43)
HAFNIUM OXIDE Pancreatic Adenocarcinoma	M.D. Anderson Cancer Center	P1	CC (43)
HAFNIUM OXIDE Pancreatic Ductal Adenocarcinoma	M.D. Anderson Cancer Center	P1	CC (43)
HAFNIUM OXIDE Lung Carcinoma	M.D. Anderson Cancer Center	P1	CC (43)
HAFNIUM OXIDE Malignant Pancreatic Neoplasm	M.D. Anderson Cancer Center	P1	CC (43)
HAFNIUM OXIDE Lung Cancer	M.D. Anderson Cancer Center	P1	CC (43)
her2bbζ/cd19t+ t cells Leptomeningeal Melanoma	M.D. Anderson Cancer Center	P1	CC (43)
il-15 enhanced engineered nk cells Lymphoid System Disorder	M.D. Anderson Cancer Center	P1	CC (43)
Imiquimod Malignant Pancreatic Neoplasm	M.D. Anderson Cancer Center	P1	CC (43)
Immunoglobulin G1 [de-236-glycine,267-glutamic acid,de-C-terminal lysine], anti-(human tumor necrosis factor receptor TNFRSF9) (human-Mus musculus monoclonal LVGN6051 ?1-chain), disulfide with human-Mus musculus monoclonal LVGN6051 ?-chain, dimer Esophageal Cancer	M.D. Anderson Cancer Center	P1	CC (43)
Immunoglobulin G1 [de-236-glycine,267-glutamic acid,de-C-terminal lysine], anti-(human tumor necrosis factor receptor TNFRSF9) (human-Mus musculus monoclonal LVGN6051 ?1-chain), disulfide with human-Mus musculus monoclonal LVGN6051 ?-chain, dimer Head And Neck Carcinoma	M.D. Anderson Cancer Center	P1	CC (43)
Immunoglobulin G1 [de-236-glycine,267-glutamic acid,de-C-terminal lysine], anti-(human tumor necrosis factor receptor TNFRSF9) (human-Mus musculus monoclonal LVGN6051 ?1-chain), disulfide with human-Mus musculus monoclonal LVGN6051 ?-chain, dimer Hepatocellular Carcinoma	M.D. Anderson Cancer Center	P1	CC (43)
Immunoglobulin G1 [de-236-glycine,267-glutamic acid,de-C-terminal lysine], anti-(human tumor necrosis factor receptor TNFRSF9) (human-Mus musculus monoclonal LVGN6051 ?1-chain), disulfide with human-Mus musculus monoclonal LVGN6051 ?-chain, dimer Ovarian Carcinoma	M.D. Anderson Cancer Center	P1	CC (43)
Immunoglobulin G1 [de-236-glycine,267-glutamic acid,de-C-terminal lysine], anti-(human tumor necrosis factor receptor TNFRSF9) (human-Mus musculus monoclonal LVGN6051 ?1-chain), disulfide with human-Mus musculus monoclonal LVGN6051 ?-chain, dimer Soft Tissue Sarcoma	M.D. Anderson Cancer Center	P1	CC (43)
Immunoglobulin G1 [de-236-glycine,de-C-terminal lysine], anti-(human CD40 antigen) (human monoclonal LVGN7409 ?1-chain), disulfide with human monoclonal LVGN7409 ?-chain, dimer Esophageal Cancer	M.D. Anderson Cancer Center	P1	CC (43)
Immunoglobulin G1 [de-236-glycine,de-C-terminal lysine], anti-(human CD40 antigen) (human monoclonal LVGN7409 ?1-chain), disulfide with human monoclonal LVGN7409 ?-chain, dimer Head And Neck Carcinoma	M.D. Anderson Cancer Center	P1	CC (43)
Immunoglobulin G1 [de-236-glycine,de-C-terminal lysine], anti-(human CD40 antigen) (human monoclonal LVGN7409 ?1-chain), disulfide with human monoclonal LVGN7409 ?-chain, dimer Hepatocellular Carcinoma	M.D. Anderson Cancer Center	P1	CC (43)
Immunoglobulin G1 [de-236-glycine,de-C-terminal lysine], anti-(human CD40 antigen) (human monoclonal LVGN7409 ?1-chain), disulfide with human monoclonal LVGN7409 ?-chain, dimer Ovarian Carcinoma	M.D. Anderson Cancer Center	P1	CC (43)
Immunoglobulin G1 [de-236-glycine,de-C-terminal lysine], anti-(human CD40 antigen) (human monoclonal LVGN7409 ?1-chain), disulfide with human monoclonal LVGN7409 ?-chain, dimer Soft Tissue Sarcoma	M.D. Anderson Cancer Center	P1	CC (43)
Infliximab Lung Carcinoma In Situ	M.D. Anderson Cancer Center	P1	CC (43)

Showing 901 to 925 of 1,179 assets

PreviousPage 37 of 48Next